Effect of hyperbaric oxygen on patients with traumatic brain injury

J. W. Lin, J. T. Tsai, L. M. Lee, C. M. Lin, C. C. Hung, K. S. Hung, W. Y. Chen, L. Wei, C. P. Ko, Yu-Kai Su, Wen Ta Chiu

Research output: Chapter in Book/Report/Conference proceedingChapter

35 Citations (Scopus)

Abstract

Hyperbaric oxygen therapy (HBOT) is the medical therapeutic use of oxygen at a higher atmospheric pressure. The United States Food and Drug Administration have approved several clinical applications for HBOT, but HBOT in traumatic brain injury (TBI) patients has still remained in controversial. The purpose of our study is to evaluate the benefit of HBOT on the prognosis of subacute TBI patients. We prospectively enrolled 44 patients with TBI from November 1, 2004 to October 31, 2005. The study group randomly included 22 patients who received HBOT after the patients' condition stabilization, and the other 22 corresponding condition patients were assigned into the matched control group who were not treated with HBOT. The clinical conditions of the patients were evaluated with the Glasgow Coma Scale (GCS) and Glasgow Outcome Scale (GOS) before and 3 to 6 months after HBOT. The GCS of the HBOT group was improved from 11.1 to 13.5 in average, and from 10.4 to 11.5 (p<0.05) for control group. Among those patients with GOS = 4 before the HBOT, significant GOS improvement was observed in the HBOT group 6 months after HBOT. Based on this study, HBOT can provide some benefits for the subacute TBI patients with minimal adverse side effects.

Original languageEnglish
Title of host publicationReconstructive Neurosurgery
PublisherSpringer-Verlag Wien
Pages145-149
Number of pages5
Edition101
ISBN (Print)9783211782040
DOIs
Publication statusPublished - Jan 1 2008

Publication series

NameActa Neurochirurgica, Supplementum
Number101
ISSN (Print)0065-1419

Fingerprint

Hyperbaric Oxygenation
Oxygen
Glasgow Outcome Scale
Glasgow Coma Scale
Traumatic Brain Injury
Control Groups
Atmospheric Pressure
Therapeutic Uses
United States Food and Drug Administration
Research Design

Keywords

  • Glasgow Coma Scale (GCS)
  • Glasgow Outcome Scale (GOS)
  • hyperbaric oxygen
  • Traumatic brain injury

ASJC Scopus subject areas

  • Surgery
  • Clinical Neurology

Cite this

Lin, J. W., Tsai, J. T., Lee, L. M., Lin, C. M., Hung, C. C., Hung, K. S., ... Chiu, W. T. (2008). Effect of hyperbaric oxygen on patients with traumatic brain injury. In Reconstructive Neurosurgery (101 ed., pp. 145-149). (Acta Neurochirurgica, Supplementum; No. 101). Springer-Verlag Wien. https://doi.org/10.1007/978-3-211-78205-7_25

Effect of hyperbaric oxygen on patients with traumatic brain injury. / Lin, J. W.; Tsai, J. T.; Lee, L. M.; Lin, C. M.; Hung, C. C.; Hung, K. S.; Chen, W. Y.; Wei, L.; Ko, C. P.; Su, Yu-Kai; Chiu, Wen Ta.

Reconstructive Neurosurgery. 101. ed. Springer-Verlag Wien, 2008. p. 145-149 (Acta Neurochirurgica, Supplementum; No. 101).

Research output: Chapter in Book/Report/Conference proceedingChapter

Lin, JW, Tsai, JT, Lee, LM, Lin, CM, Hung, CC, Hung, KS, Chen, WY, Wei, L, Ko, CP, Su, Y-K & Chiu, WT 2008, Effect of hyperbaric oxygen on patients with traumatic brain injury. in Reconstructive Neurosurgery. 101 edn, Acta Neurochirurgica, Supplementum, no. 101, Springer-Verlag Wien, pp. 145-149. https://doi.org/10.1007/978-3-211-78205-7_25
Lin JW, Tsai JT, Lee LM, Lin CM, Hung CC, Hung KS et al. Effect of hyperbaric oxygen on patients with traumatic brain injury. In Reconstructive Neurosurgery. 101 ed. Springer-Verlag Wien. 2008. p. 145-149. (Acta Neurochirurgica, Supplementum; 101). https://doi.org/10.1007/978-3-211-78205-7_25
Lin, J. W. ; Tsai, J. T. ; Lee, L. M. ; Lin, C. M. ; Hung, C. C. ; Hung, K. S. ; Chen, W. Y. ; Wei, L. ; Ko, C. P. ; Su, Yu-Kai ; Chiu, Wen Ta. / Effect of hyperbaric oxygen on patients with traumatic brain injury. Reconstructive Neurosurgery. 101. ed. Springer-Verlag Wien, 2008. pp. 145-149 (Acta Neurochirurgica, Supplementum; 101).
@inbook{20fa23ce465445a39ff05d963cb219c5,
title = "Effect of hyperbaric oxygen on patients with traumatic brain injury",
abstract = "Hyperbaric oxygen therapy (HBOT) is the medical therapeutic use of oxygen at a higher atmospheric pressure. The United States Food and Drug Administration have approved several clinical applications for HBOT, but HBOT in traumatic brain injury (TBI) patients has still remained in controversial. The purpose of our study is to evaluate the benefit of HBOT on the prognosis of subacute TBI patients. We prospectively enrolled 44 patients with TBI from November 1, 2004 to October 31, 2005. The study group randomly included 22 patients who received HBOT after the patients' condition stabilization, and the other 22 corresponding condition patients were assigned into the matched control group who were not treated with HBOT. The clinical conditions of the patients were evaluated with the Glasgow Coma Scale (GCS) and Glasgow Outcome Scale (GOS) before and 3 to 6 months after HBOT. The GCS of the HBOT group was improved from 11.1 to 13.5 in average, and from 10.4 to 11.5 (p<0.05) for control group. Among those patients with GOS = 4 before the HBOT, significant GOS improvement was observed in the HBOT group 6 months after HBOT. Based on this study, HBOT can provide some benefits for the subacute TBI patients with minimal adverse side effects.",
keywords = "Glasgow Coma Scale (GCS), Glasgow Outcome Scale (GOS), hyperbaric oxygen, Traumatic brain injury",
author = "Lin, {J. W.} and Tsai, {J. T.} and Lee, {L. M.} and Lin, {C. M.} and Hung, {C. C.} and Hung, {K. S.} and Chen, {W. Y.} and L. Wei and Ko, {C. P.} and Yu-Kai Su and Chiu, {Wen Ta}",
year = "2008",
month = "1",
day = "1",
doi = "10.1007/978-3-211-78205-7_25",
language = "English",
isbn = "9783211782040",
series = "Acta Neurochirurgica, Supplementum",
publisher = "Springer-Verlag Wien",
number = "101",
pages = "145--149",
booktitle = "Reconstructive Neurosurgery",
address = "Austria",
edition = "101",

}

TY - CHAP

T1 - Effect of hyperbaric oxygen on patients with traumatic brain injury

AU - Lin, J. W.

AU - Tsai, J. T.

AU - Lee, L. M.

AU - Lin, C. M.

AU - Hung, C. C.

AU - Hung, K. S.

AU - Chen, W. Y.

AU - Wei, L.

AU - Ko, C. P.

AU - Su, Yu-Kai

AU - Chiu, Wen Ta

PY - 2008/1/1

Y1 - 2008/1/1

N2 - Hyperbaric oxygen therapy (HBOT) is the medical therapeutic use of oxygen at a higher atmospheric pressure. The United States Food and Drug Administration have approved several clinical applications for HBOT, but HBOT in traumatic brain injury (TBI) patients has still remained in controversial. The purpose of our study is to evaluate the benefit of HBOT on the prognosis of subacute TBI patients. We prospectively enrolled 44 patients with TBI from November 1, 2004 to October 31, 2005. The study group randomly included 22 patients who received HBOT after the patients' condition stabilization, and the other 22 corresponding condition patients were assigned into the matched control group who were not treated with HBOT. The clinical conditions of the patients were evaluated with the Glasgow Coma Scale (GCS) and Glasgow Outcome Scale (GOS) before and 3 to 6 months after HBOT. The GCS of the HBOT group was improved from 11.1 to 13.5 in average, and from 10.4 to 11.5 (p<0.05) for control group. Among those patients with GOS = 4 before the HBOT, significant GOS improvement was observed in the HBOT group 6 months after HBOT. Based on this study, HBOT can provide some benefits for the subacute TBI patients with minimal adverse side effects.

AB - Hyperbaric oxygen therapy (HBOT) is the medical therapeutic use of oxygen at a higher atmospheric pressure. The United States Food and Drug Administration have approved several clinical applications for HBOT, but HBOT in traumatic brain injury (TBI) patients has still remained in controversial. The purpose of our study is to evaluate the benefit of HBOT on the prognosis of subacute TBI patients. We prospectively enrolled 44 patients with TBI from November 1, 2004 to October 31, 2005. The study group randomly included 22 patients who received HBOT after the patients' condition stabilization, and the other 22 corresponding condition patients were assigned into the matched control group who were not treated with HBOT. The clinical conditions of the patients were evaluated with the Glasgow Coma Scale (GCS) and Glasgow Outcome Scale (GOS) before and 3 to 6 months after HBOT. The GCS of the HBOT group was improved from 11.1 to 13.5 in average, and from 10.4 to 11.5 (p<0.05) for control group. Among those patients with GOS = 4 before the HBOT, significant GOS improvement was observed in the HBOT group 6 months after HBOT. Based on this study, HBOT can provide some benefits for the subacute TBI patients with minimal adverse side effects.

KW - Glasgow Coma Scale (GCS)

KW - Glasgow Outcome Scale (GOS)

KW - hyperbaric oxygen

KW - Traumatic brain injury

UR - http://www.scopus.com/inward/record.url?scp=85052608865&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052608865&partnerID=8YFLogxK

U2 - 10.1007/978-3-211-78205-7_25

DO - 10.1007/978-3-211-78205-7_25

M3 - Chapter

C2 - 18642650

AN - SCOPUS:85052608865

SN - 9783211782040

T3 - Acta Neurochirurgica, Supplementum

SP - 145

EP - 149

BT - Reconstructive Neurosurgery

PB - Springer-Verlag Wien

ER -